Opioid Use Disorder Cortical Organoids for Disease Modelling
Source Dwivedi et al., 2023 · University of California, San Diego · 10.1038/s41398-023-02397-3
Abstract
This protocol describes the generation of human iPSC-derived cortical organoids (hCOs) and their chronic treatment with methadone (1 μM) for 50 days to model the effects of prenatal methadone exposure on early cortical development. Bulk mRNA-sequencing reveals that methadone alters transcriptional programs associated with synapse formation, extracellular matrix remodeling, and ciliary function, providing insights into the molecular mechanisms underlying neurocognitive deficits linked to maternal opioid addiction treatment.
Protocol overview
23 steps across 7 phases
- a iPSC Culture
- b Cortical Organoid Generation
- a Methadone Stock Solution Preparation
- b Vehicle Control Preparation
- a Neural Proliferation Medium with Methadone
- a Neural Proliferation II Medium (Days 16-22)
- b Neural Maturation Medium (Days 28-60)
- a Organoid Harvest and Pellet Formation
- b PBS Wash and Second Centrifugation
- c Snap Freezing
- d Storage
- e RNA Extraction
- a RNA Integrity Assessment
- b PolyA+ Library Preparation
- c Multiplexing and Sequencing
- a Organoid Generation for Western Blot
- b Organoid Collection at 4 Months
- c Protein Extraction and Quantification
- d SDS-PAGE and Transfer
- e Blocking and Antibody Incubation
- f Secondary Antibody Incubation and Detection
- g Band Intensity Analysis
- h Statistical Analysis
Full SOP
Full SOPs need an account and a plan
Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.
Create an accountAlready registered? Log in
Attribution
This SOP was written by Organthis based on the published method in Dwivedi et al., 2023. Once the originating laboratory has confirmed it, the SOP is marked Verified.
Something wrong with this entry? Report an issue with this protocol